Tourmaline Bio Announces Closing of Merger with Talaris
Tourmaline will be focused on advancing TOUR006, its differentiated anti-IL-6 antibody, to treat thyroid eye disease (TED), atherosclerotic cardiovascular...
Source: globenewswire.com
Stay updated with breaking news from Nasdaq Trml. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tourmaline will be focused on advancing TOUR006, its differentiated anti-IL-6 antibody, to treat thyroid eye disease (TED), atherosclerotic cardiovascular...